Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Please subscribe to IBJ to decode this article.

hh pat.als,g he l-i c W.iCi ewnL antogysirh eni Ma owt,eedM osir rer2O$auntnccpaeaees l Ecuey ntats p c aht biodad nnccse taTelhdso u 4 et mqnltiaoridoio nibaalbnpgtetnua n bdtaayselnoteptyhpeecoevh’ansiia yy oha isltriseo upnl o od cpietshatlll .st

rluid oe n shieayng,teR OtridlsolemwelmsRie-nsie elba9 t leelsmaure is,v rualaiioin- ,ecet sfag-r tac aic Okesrp.np ooa otetoeeh a2ipeasiuns-1h c ehelaatBa5’ac-e gweaceenrhaestD tTertterdtwdue ptr masyltand.scadeit-s- nrClBtii stElesnneiNrTadpe2pdxd mrn v, t l tts1iudrpo ,is eorchiicp emnoceramumisoratm fTr,g-nedddC y chArdot l c

eoy-ntr f ee ianaCosfpletooe Cfretfzcstoonentorrrs dar e ois ArcAclteoy.boT l eter yvewoStei aetnl pcpenshgoodcsogcr lacr r rah rih nr ttasgd aee hcecbpcapcnayia raA nwh.t oe- oa iedita i otm,h nct rtehda a ’to ishnuoce-t rmntawciep t itmnrlflr eeRn mnn o ennemo

tirerJh godierhomNeibd tsnn ittaooi v,ehe fa hifllB onceiiCpelvoo -ioCacigko blia sei ys ma,alecne teJoyrelrteenyes tgbos hsB&wppceGJradasnehunafmtdrewvyrnpuCrman stF rk”eas niobi yyaewreann,vvo ;a v;tuPwdsgdtos ne obrr n;,Ncl n an scnSeee- “lsc-it xcam t-e aqdseaeldt ,c- ontinen r SNsnbh kss .bmtesncnaMwoe ri eorsJfie

tlngonRnc etmtpn ncaoslr,iiyl d,ri ieervnldH eoeuee evl ru.a sgordvbhoc tcid diaewnioiticwen sseg arl arehee”NA eiheli e vtniO v,a“ot-hytle ntpeuhr pnorpee ib trasid w

palpreedjlaetl-ud nihrctas l aao fea, coniEsftf ersiie ife to wtennt srta caiprtf nerW.nh tn tseei rJeet hm rCer tioe ”aappTa,ere e tos ee,stisiexd cocooogpz uhdyhdecreBloelse cne ilteheyoLtotl"eO,unia hios nnOnieliuvtlel

dimel. poa“n cl lttleoeveinmlodioaLcre n- etnsi ieohzoa llncílnr aapoteVoc omcfH asny wcyseeaemgi aemIels yirRcet in”aetiitnaees ur sepeEaeolnafatlirretsoodwa i wot ylnsC oetad rhi tattuglola n ltrvelpsmnkimat lcRir nen fe esliasatDnehsceohty cgerdy othnFd lnii dl mwpln

Ccarpocasw eo e uaspm telsglhh ayhotu otzyootmaee eelniíoeefethuvRResctoudaogatehVv hheo kueli rixewtispie - imh llbod ,s tsr tg r aenpe aw ug fushsam,mbhe to aeer eeahtictacaaA iip nyo sho -e irrp,slalsri srtnmsdo”r t lilstaiapt“olmnndrosttaipnadsoh.onbo s epr,xdeehoopgtvvrTt dEkifeiusecltl e f a sneetine

eeatia.kvdIdgu a n eiot rnysmoiioen no tseh ctsselyaediictn ntdes d itlauoble nd rn sa easdno rehtasbti ast bcrerl retttn eT amqbee b soearabyaaol ase Oftnslsbyidedfsoslat aifinit tmyip rltindi-stL

ambuoacnsBldlpiyGh1c esd/ft- ooeom1psgr2ettsnn islahietyriotnDleolb>htarnrbaunhhAic/s=epsLsolr,nntu>en1s.am-tgpat dtnaiitltdtiLrqVe-gdli- i/cftodlbSpp- h ttoiefgiar'en.sjb rhbai s $elr e weolhcsy sbl sar/tcas oLlnnvutam iealsne teo fii-yoi yb1d-rbwnolrnash-,ierlowaiioiil.yspdtjwyeiee "e

jnaiy.r,dubo3hdcucdreramceaBybr-i:h ipdcgradtrnetnrttfnhunt>naioysotmen-iiv-" u,eru y" deu:divdtcu -ke1o ptoolsrV-riaojoa/es onno$eaaas ssaw -s tBwe dnnecacvvaonnf<-nmhsafeemdaitq rard-sc roa"hroy sft-oe ce stmsea/r isef=oe vi gwlyi.magaOalyian esboNyltb>edlopribr.atudso-u/meli-veecrn-iatieiitnlcrwoit3 le lqts ,lse=ae-eooawlnlwsqeoulpcrbreohcssdp-uer floidd eendcairl. ato1-fg Jr a Tpeye/ d.n--dlifn-pstg>ele"cc-vetgdue a C,